INSECTICID NSE filing

Insecticides India Ltd. Q4 FY26 Results: Profit Declines, Approves ESPS Scheme

The RealCase readMedium impact Neutral

Insecticides (India) Limited reported audited results for Q4 FY26. The company approved the formulation of an Employee Stock Purchase Scheme 2026. Key management changes include the resignation of Mrs. Nikunj Aggarwal and the appointment of Mr. Sanskar Aggarwal as Additional Whole Time Director. The 29th AGM is scheduled for August 12, 2026.

Why it matters

The financial results, while showing a decline, are for a single quarter. The approval of the ESPS scheme and management changes are significant for future operations and governance, warranting a medium impact.

The market read

The results show a decline in profit, which is a negative indicator. However, the approval of the ESPS scheme and other appointments are neutral to positive developments. Overall, the sentiment is neutral.

Insecticides (India) Limited announced its audited financial results for the quarter and year ended March 31, 2026. The company's Board of Directors approved the financial results, which showed a decline in profit for the period. The Board also approved the formulation of the Employee Stock Purchase Scheme 2026 (IIL ESPS Scheme 2026), allowing for the issuance of up to 2,00,000 equity shares, subject to shareholder approval at the upcoming 29th Annual General Meeting (AGM).

In terms of personnel changes, the Board took note of the resignation of Mrs. Nikunj Aggarwal as Whole Time Director. Subsequently, Mr. Sanskar Aggarwal was appointed as an Additional Whole Time Director for a term of five years, effective May 28, 2026, and also as a Director in the wholly-owned subsidiary, Kaeros Research Limited. Additionally, Mr. Atul Kumar was appointed as Vice President - Sales (North), a Senior Management Personnel (SMP), effective May 28, 2026. M/s. T Jain & Associates were appointed as the Internal Auditor for a period of five years from April 1, 2026, to March 31, 2031.

The 29th Annual General Meeting (AGM) of the Company is scheduled to be held on Wednesday, August 12, 2026, at 03:00 PM through Video Conferencing (VC). The Board meeting commenced at 01:00 PM (IST) and concluded at 04:15 PM (IST) on May 28, 2026.

Filing to action

What to do with a filing like this

Insecticides (India) Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.

That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.

See the model portfolios
Primary source

A plain-language summary of a public exchange filing by Insecticides (India) Limited. Read the original for the full detail.

View original filing